An J, An S, Choi M, Jung JH, Kim B (2022) Natural products for esophageal cancer therapy: from traditional medicine to modern drug discovery. Int J Mol Sci 23:13558. https://doi.org/10.3390/ijms232113558

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arnold M, Ferlay J, Van Berge Henegouwen MI, Soerjomataram I (2020) Global burden of oesophageal and gastric cancer by histology and subsite in 2018. Gut 69:1564–1571. https://doi.org/10.1136/gutjnl-2020-321600

Article  PubMed  Google Scholar 

Bansal A, Celeste Simon M (2018) Glutathione metabolism in cancer progression and treatment resistance. J Cell Biol 217:2291–2298. https://doi.org/10.1083/jcb.201804161

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blank S, Nienhüser H, Dreikhausen L, Sisic L, Heger U, Ott K, Schmidt T (2017) Inflammatory cytokines are associated with response and prognosis in patients with esophageal cancer. Oncotarget 8:47518–47532. https://doi.org/10.18632/oncotarget.17671

Article  PubMed  PubMed Central  Google Scholar 

Brand TM, Iida M, Luthar N, Starr MM, Huppert EJ, Wheeler DL (2013) Nuclear EGFR as a molecular target in cancer. Radiother Oncol 108:370–377. https://doi.org/10.1016/j.radonc.2013.06.010

Article  CAS  PubMed  Google Scholar 

Carneiro BA, El-Deiry WS (2020) Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol 17:395–417. https://doi.org/10.1038/s41571-020-0341-y

Article  PubMed  PubMed Central  Google Scholar 

Chae JB, Kim JS, Choi ST, Lee SG, Ojulari OV, Kang YJ, Kwon TK, Nam J-O (2021) Farrerol induces cancer cell death via ERK activation in SKOV3 cells and attenuates TNF-α-mediated lipolysis. Int J Mol Sci 22:9400. https://doi.org/10.3390/ijms22179400

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen R, Zheng R, Zhang S, Wang S, Sun K, Zeng H, Li L, Wei W, He J (2023) Patterns and trends in esophageal cancer incidence and mortality in China: an analysis based on cancer registry data. J Natl Cancer Cent 25:21–27. https://doi.org/10.1016/j.jncc.2023.01.002

Article  Google Scholar 

Cui B, Zhang S, Wang Y, Guo Y (2019) Farrerol attenuates β-amyloid-induced oxidative stress and inflammation through Nrf2/Keap1 pathway in a microglia cell line. Biomed Pharmacother 109:112–119. https://doi.org/10.1016/j.biopha.2018.10.053

Article  CAS  PubMed  Google Scholar 

Evan GI, Vousden KH (2001) Proliferation, cell cycle and apoptosis in cancer. Nature 411:342–348. https://doi.org/10.1038/35077213

Article  CAS  PubMed  Google Scholar 

Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70. https://doi.org/10.1007/s00262-010-0968-0

Article  CAS  PubMed  Google Scholar 

Hoshino A, Ariyoshi M, Okawa Y, Matoba S (2014) Inhibition of p53 preserves Parkin-mediated mitophagy and pancreatic β-cell function in diabetes. Proc Natl Acad Sci U S A 111:3116–3121. https://doi.org/10.1073/pnas.1318951111

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang S, Guo Y, Li Z, Zhang Y, Zhou T, You W, Pan K, Li W (2020) A systematic review of metabolomic profiling of gastric cancer and esophageal cancer. Cancer Biol Med 17:181–198. https://doi.org/10.20892/j.issn.2095-3941.2019.0348

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kastan MB, Bartek J (2004) Cell-cycle checkpoints and cancer. Nature 432:316–23. https://doi.org/10.1038/nature03097

Article  CAS  PubMed  Google Scholar 

Katz L, Baltz RH (2016) Natural product discovery: past, present, and future. J Ind Microbiol Biotechnol 43:155–176. https://doi.org/10.1007/s10295-015-1723-5

Article  CAS  PubMed  Google Scholar 

Khan AQ, Rashid K, AlAmodi AA, Agha MV, Akhtar S, Hakeem I, Raza SS, Uddin S (2021) Reactive oxygen species (ROS) in cancer pathogenesis and therapy: an update on the role of ROS in anticancer action of benzophenanthridine alkaloids. Biomed Pharmacother 143:112142. https://doi.org/10.1016/j.biopha.2021.112142

Article  CAS  PubMed  Google Scholar 

Lee HJ, Zhuang G, Cao Y, Du P, Kim HJ, Settleman J (2014) Drug resistance via feedback activation of stat3 in oncogene-addicted cancer cells. Cancer Cell 26:207–221. https://doi.org/10.1016/j.ccr.2014.05.019

Article  CAS  PubMed  Google Scholar 

Liu J, Wang H, Wang Y, Yin Y, Du Z, Liu Z, Yang J, Hu S, Wang C, Chen Y (2014) The stem cell adjuvant with Exendin-4 repairs the heart after myocardial infarction via STAT3 activation. J Cell Mol Med 18:1381–1391. https://doi.org/10.1111/jcmm.12272

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu E, Liang T, Wang X, Ban S, Han L, Li Q (2015) Apoptosis induced by farrerol in human gastric cancer SGC-7901 cells through the mitochondrial-mediated pathway. Eur J Cancer Prev 24:365–372. https://doi.org/10.1097/CEJ.0000000000000104

Article  CAS  PubMed  Google Scholar 

Luo Y, Cobb RE, Zhao H (2014) Recent advances in natural product discovery. Curr Opin Biotechnol 30:230–237. https://doi.org/10.1016/j.copbio.2014.09.002

Article  CAS  PubMed  Google Scholar 

Ma N, Wei W, Fan X, Ci X (2019) Farrerol attenuates cisplatin-induced nephrotoxicity by inhibiting the reactive oxygen species-mediated oxidation, inflammation, and apoptotic signaling pathways. Front Physiol 10:1419. https://doi.org/10.3389/fphys.2019.01419

Article  PubMed  PubMed Central  Google Scholar 

Morgan E, Soerjomataram I, Rumgay H, Coleman HG, Thrift AP, Vignat J, Laversanne M, Ferlay J, Arnold M (2022) The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology 163:649–658. https://doi.org/10.1053/j.gastro.2022.05.054

Article  PubMed  Google Scholar 

Nicholson RI, Gee JMW, Harper ME (2001) EGFR and cancer prognosis. Eur J Cancer 37(Suppl 4):S9-15. https://doi.org/10.1016/s0959-8049(01)00231-3

Article  CAS  PubMed  Google Scholar 

Ooki A, Osumi H, Chin K, Watanabe M, Yamaguchi K. (2023) Potent molecular-targeted therapies for advanced esophageal squamous cell carcinoma. Ther Adv Med Oncol 15. https://doi.org/10.1177/17588359221138377

Perillo B, Di Donato M, Pezone A, Di Zazzo E, Giovannelli P, Galasso G, Castoria G, Migliaccio A (2020) ROS in cancer therapy: the bright side of the moon. Exp Mol Med 52:192–203. https://doi.org/10.1038/s12276-020-0384-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ponte LG, Pavan IC, Mancini MC, da Silva LG, Morelli AP, Severino MB, Bezerra RM, Simabuco FM (2021) The hallmarks of flavonoids in cancer. Molecules 26:2029. https://doi.org/10.3390/molecules26072029

Article  CAS  PubMed  PubMed Central  Google Scholar 

Qin X, Xu X, Hou X, Liang R, Chen L, Hao Y, Gao A, Du X, Zhao L, Shi Y, Li Q (2022) The pharmacological properties and corresponding mechanisms of farrerol: a comprehensive review. Pharm Biol 60:9–16. https://doi.org/10.1080/13880209.2021.2006723

Article  CAS  PubMed  Google Scholar 

Ran X, Li Y, Chen G, Fu S, He D, Huang B, Wei L, Lin Y, Guo Y, Hu G (2018) Farrerol ameliorates TNBS-induced colonic inflammation by inhibiting ERK1/2, JNK1/2, and NF-κB signaling pathway. Int J Mol Sci 19:2037. https://doi.org/10.3390/ijms19072037

Article  CAS  PubMed  PubMed Central